Loridapa-M Tablet ER

Overview Loridapa-M Tablet ER

GlucoDuo XR is a dual-action tablet prescribed for managing type 2 diabetes. It effectively regulates elevated blood glucose, thereby lessening the likelihood of severe diabetic complications and contributing to cardiovascular health. GlucoDuo XR can be ingested with food; consistent daily dosing, at the same time each day, aids adherence. Dosage is determined by your physician; cessation requires medical consultation, as abrupt discontinuation can lead to dangerously high blood sugar, potentially causing kidney failure and vision impairment. This medication complements a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management under medical guidance. Commonly reported side effects include upper respiratory discomfort (sore throat, nasal congestion, rhinorrhea), headache, gastrointestinal upset (nausea, vomiting, diarrhea). Adequate hydration is crucial to prevent dehydration. Genital fungal infections may occur; maintaining proper hygiene is preventative. Prior to commencing treatment, disclose any kidney or liver conditions, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals should seek medical advice before using GlucoDuo XR. Limit alcohol consumption, as it might intensify adverse reactions. Regular blood glucose monitoring is essential during treatment.

Uses of Loridapa-M Tablet ER

Managing type 2 diabetes

Major Benefits of Loridapa-M Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Loridapa-M Extended-Release Tablets. Ingest the tablets whole; do not crush, chew, or break them before swallowing. Consume this medication with food.

Common Side effects of Loridapa-M Tablet ER:

• Nausea
• Vomiting
• Diarrhea
• Genital fungal infection
• Nasopharyngitis (inflammation of the throat and nasal passages)
• Urinary tract infection
• Polyuria
• Flatulence
• Skin rash
• Taste change
• Difficulty in urination
• Hypoglycemia (low blood glucose level)
• Tremors
• Dizziness
• Back pain
• Increased hematocrit
• Decreased creatinine clearance
• Dyslipidemia

How to use Loridapa-M Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Loridapa-M Extended-Release tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Consume Loridapa-M ER with a meal.

How Loridapa-M Tablet ER works:

Loridapa-M Extended-Release tablets combine dapagliflozin and metformin, two agents that manage blood glucose levels. Dapagliflozin promotes glucose excretion via the kidneys, while metformin reduces hepatic glucose production, slows intestinal glucose uptake, and enhances insulin responsiveness. This dual action optimizes glycemic control.

What if you forget to take Loridapa-M Tablet ER :

Should you forget a Loridapa-M Tablet ER dose, ingest it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.